COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
Rosano G. Jankowska E.A. Ray R. Metra M. Abdelhamid M. Adamopoulos S. Anker S.D. Bayes-Genis A. Belenkov Y. Gal T.B. Böhm M. Chioncel O. Cohen-Solal A. Farmakis D. Filippatos G. González A. Gustafsson F. Hill L. Jaarsma T. Jouhra F. Lainscak M. Lambrinou E. Lopatin Y. Lund L.H. Milicic D. Moura B. Mullens W. Piepoli M.F. Ponikowski P. Rakisheva A. Ristic A. Savarese G. Seferovic P. Senni M. Thum T. Tocchetti C.G. Van Linthout S. Volterrani M. Coats A.J.S.
November 2021John Wiley and Sons Ltd
European Journal of Heart Failure
2021#23Issue 111806 - 1818 pp.
Patients with heart failure (HF) who contract SARS-CoV-2 infection are at a higher risk of cardiovascular and non-cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID-19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID-19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID-19 vaccination scheme in patients with HF. COVID-19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID-19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID-19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS-CoV-2 infection (including the COVID-19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF.
COVID-19 , Heart failure , SARS-CoV-2 , Vaccination
Text of the article Перейти на текст статьи
IRCCS San Raffaele, Rome, Italy
Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland
Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St Georges, University of London, St Georges Hospital, London, United Kingdom
Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy
Faculty of Medicine, Kasr Al Ainy, Department of Cardiology, Cairo University, Giza, Egypt
Heart Failure - Transplant - Mechanical Circulatory Support Unit, Onassis Cardiac Surgery Center, Athens, Greece
Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany
Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona & CIBERCV, Instituto de Salud Carlos III, Madrid, Spain
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel, & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Saarland University, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany
Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’, University of Medicine Carol Davila, Bucharest, Romania
UMR-S 942 Research Unit, Paris University, Lariboisiere Hospital, Cardiology Department, AP-HP, Paris, France
University of Cyprus Medical School, Nicosia, Cyprus
National and Kapodistrian University of Athens, School of Medicine, University Hospital Attikon, Athens, Greece
Program of Cardiovascular Diseases, CIMA Universidad de Navarra, IdiSNA and CIBERCV, Pamplona, Spain
Department of Cardiology, University of Copenhagen, Copenhagen, Denmark
School of Nursing & Midwifery, Queens University, Belfast, United Kingdom
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia, & Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus
Volgograd State Medical University, Regional Cardiology Centre, Volgograd, Russian Federation
Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden
University of Zagreb School of Medicine, Zagreb, Croatia
Armed Forces Hospital, Porto, & Faculty of Medicine, University of Porto, Porto, Portugal
Cardiovascular Physiology, Hasselt University, Belgium
Cardiac Unit, Guglielmo da Saliceto Hospital, University of Parma, Piacenza, Italy
Department of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan
Department of Cardiology, University Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia
Department Faculty of Medicine, University of Belgrade, Belgrade & Serbian Academy of Sciences and Arts, Belgrade, Serbia
Cardiovascular Department, Cardiology 1 Unit, Papa Giovanni XXIII Hospital Bergamo, University of Milano - Bicocca, Bergamo, Italy
Institute of Molecular and Therapeutic Strategies, Hannover & Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany
Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy
Berlin Institute of Health at Charité - Universitätmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany
Cardiovascular Pulmonary Science Department, IRCCS San Raffaele, Roma, Italy
University of Warwick, Coventry, United Kingdom
Genk, Belgium
Center for Cardiovascular Research (DZHK), Partner site Berlin, Berlin, Germany
IRCCS San Raffaele
Institute of Heart Diseases
Cardiology Clinical Academic Group
Institute of Cardiology
Faculty of Medicine
Heart Failure - Transplant - Mechanical Circulatory Support Unit
Department of Cardiology (CVK)
Heart Institute
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Department of Cardiology
Universitätsklinikum des Saarlandes
Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’
UMR-S 942 Research Unit
University of Cyprus Medical School
National and Kapodistrian University of Athens
Program of Cardiovascular Diseases
Department of Cardiology
School of Nursing & Midwifery
Department of Health
Division of Cardiology
Department of Nursing
Volgograd State Medical University
Department of Medicine
University of Zagreb School of Medicine
Armed Forces Hospital
Cardiovascular Physiology
Cardiac Unit
Department of Cardiology
Department of Cardiology
Department Faculty of Medicine
Cardiovascular Department
Institute of Molecular and Therapeutic Strategies
Department of Translational Medical Sciences
Berlin Institute of Health at Charité - Universitätmedizin Berlin
Cardiovascular Pulmonary Science Department
University of Warwick
Genk
Center for Cardiovascular Research (DZHK)
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026